Research on Wireless Brain Implant System for General Control of External Devices (RISE)

Shanghai StairMed Technology Co., Ltd.

Status

Enrolling

Conditions

Brainstem Stroke

Amyotrophic Lateral Sclerosis

Complete or Incomplete Paraplegia/quadriplegia

Spinal Cord Injury

Bilateral Upper Limb Amputation

Treatments

Device: WRS

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT06829212

PI2302-CL-01-001

2024-1325 (Other Identifier)

Details and patient eligibility

About

The clinical trial aims to evaluate the safety and efficacy of the minimally invasive, wireless brain-machine interface system (WRS) in enabling general brain control of external devices, such as a cursor and other assistive technologies, for paralyzed and amputee patients.

WRS integrates a high-throughput, ultra-flexible neural electrode with an extremely small cross-sectional size-approximately one-hundredth the diameter of a human hair. Moreover, the implantable component is fully embedded within the body, leaving no visible external traces.

Full description

The investigators' technology is designed to assist paralyzed and amputee patients in regaining certain physical functions, thereby improving participants' overall quality of life and daily convenience.

The investigators hope to enable participants to achieve general control over external devices through neural signals in this clinical trial. This eliminates the need for manual manipulation to control devices such as a cursor or other assistive technologies, which can be operated solely through thought. Such advancements will facilitate enhanced communication with loved ones, support the acquisition of new skills, and provide more accessible opportunities for entertainment.

Enrollment

4 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Aged 18-80 years (inclusive), any gender.
Diagnosed with spinal cord injury, brainstem stroke, amyotrophic lateral sclerosis, or other motor neuron diseases causing partial or complete paralysis, or bilateral upper limb amputation.
Diagnosis stable for at least 6 months before screening, with the condition present for at least 1 year.
Willing to follow the study protocol and attend all visits, with or without caregiver assistance.
Informed consent signed by participant and/or caregiver, with full understanding of the trial's purpose.

Exclusion criteria

Previous implantation of metal objects or devices (except dental implants or non-impacting implants).
Long-term use of anticoagulants/antiplatelets with insufficient cessation, or abnormal coagulation test results.
Unable to tolerate anesthesia or surgery.
Severe neurological disorders or brain injury leading to significant dysfunction.
Scalp conditions that may impair wound healing.
Acute or severe infections.
Cognitive impairment or psychiatric disorders.
Severe dysfunction of vital organs, malignancies, or autoimmune diseases.
Life expectancy under 1 year.
Drug or alcohol abuse.
Pregnant, breastfeeding, or planning pregnancy during the study.
Other conditions deemed unsuitable by the investigator.